{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-014493","form_type":"8-K","ticker":"GYRE","cik":"0001124105","company_name":"GYRE THERAPEUTICS, INC.","filed_at":"2024-03-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.452256+00:00","generated_at":"2026-06-04T09:33:38.093403+00:00","sec_items":["5.02","1.01","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Gyre Therapeutics appoints Rodney Nussbaum to Board and Audit Committee","bullets":["Rodney Nussbaum appointed Class III director effective March 20, 2024; joins Audit Committee.","Nussbaum is a retired CPA with 40 years at Ernst & Young, KPMG, and Arthur Andersen.","Currently Managing Executive of Atago Advisory, LLC, an accounting advisory firm.","Compensation per non-employee director policy; enters standard indemnification agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-014493","json":"https://secwatch.observer/filing/0001140361-24-014493.json","markdown":"https://secwatch.observer/filing/0001140361-24-014493.md","text":"https://secwatch.observer/filing/0001140361-24-014493.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1124105/000114036124014493/0001140361-24-014493-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1124105/000114036124014493/ef20024709_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T09:33:38.093403+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7ab474ca10","claim":"Rodney Nussbaum was appointed as Director at GYRE THERAPEUTICS, INC..","evidence_excerpt":"appointed Rodney Nussbaum as a Class III director to serve until the Company’s 2024 Annual Meeting of Stockholders and until his successor is duly elected and qualified.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036124014493/0001140361-24-014493-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}